articleNature MedicineOct 19, 2015Closed access

High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response

HGHui GaoJMJoshua M. KornSFStéphane FerrettiJEJohn E. MonahanYWYouzhen Wang

Novartis Foundation · Novartis (Switzerland) · +3 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,429
total citations
FWCI
141.81
Percentile
100%
References
52
Citations per year

Authors

64

Topics & keywords

Topics
Keywords
  • Medicine
  • Clinical trial
  • Drug
  • Oncology
  • Bioinformatics
  • Modalities
  • Efficacy
  • Population
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.